A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells

Samankaltaisia teoksia

• A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
  Tekijä: Schcolnik-Cabrera, Alejandro, et al.
  Julkaistu: (2019)
• Understanding tumor anabolism and patient catabolism in cancer-associated cachexia
  Tekijä: Schcolnik-Cabrera, Alejandro, et al.
  Julkaistu: (2017)
• Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer
  Tekijä: Cervantes-Madrid, Diana, et al.
  Julkaistu: (2017)
• Comparison of DNA demethylating and histone deacetylase inhibitors hydralazine-valproate versus vorinostat-decitabine incutaneous t-cell lymphoma in HUT78 cells
  Tekijä: Schcolnik-Cabrera, Alejandro, et al.
  Julkaistu: (2018)
• The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
  Tekijä: Schcolnik-Cabrera, Alejandro, et al.
  Julkaistu: (2020)